← FDA DRUG APPROVALS

FDA ANDA · ANDA070412

FUROSEMIDE

Sponsor: WATSON LABS

APPLICATION
ANDA070412
TYPE
ANDA
ORIGINAL APPROVAL
1986-02-26
LATEST ACTION
1993-04-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FUROSEMIDEDiscontinued
FUROSEMIDE 20MG · TABLET · ORAL

Approval history

1993-04-07Labeling · Supplement 12AP
1993-01-13Labeling · Supplement 11AP
1991-05-31Manufacturing (CMC) · Supplement 7AP
1991-05-17Labeling · Supplement 9AP
1990-11-19Manufacturing (CMC) · Supplement 8AP
1990-06-29Manufacturing (CMC) · Supplement 6AP
1988-07-12Manufacturing (CMC) · Supplement 5AP
1988-07-12Manufacturing (CMC) · Supplement 3AP
1988-07-12Manufacturing (CMC) · Supplement 4AP
1988-06-07Manufacturing (CMC) · Supplement 2AP
1986-02-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →